Section: Avian Bacteria

Salmonella enteritidis in Poultry Flocks: Vaccination Strategies and Fecal Shedding Dynamics

Introduction

Salmonella enterica subspecies enterica serovar Enteritidis (Salmonella enteritidis) remains a predominant cause of foodborne salmonellosis linked to the consumption of contaminated eggs and poultry meat. The pathogen colonizes the gastrointestinal tract of chickens without necessarily inducing clinical disease, leading to silent transmission within flocks and vertical transmission to eggs. Understanding the interplay between vaccination strategies and the dynamics of fecal shedding is critical for designing effective control programs. This article provides a detailed examination of the biological mechanisms of live and inactivated vaccines, their comparative efficacy in reducing intestinal colonization and egg contamination, and the application of quantitative PCR (qPCR) for monitoring shedding patterns.

Pathogenesis and Colonization Dynamics

Salmonella enteritidis establishes infection in poultry through oral ingestion. The bacterium adheres to the intestinal epithelium via fimbriae and invades M cells overlying Peyer's patches. Following translocation, it disseminates to the liver, spleen, and reproductive tract. The ceca serve as the primary site of persistent colonization, and bacteria are shed intermittently in feces. The shedding pattern is influenced by host immune status, age, stress, and concurrent infections. Young chicks are more susceptible to colonization and shed higher numbers of bacteria compared to older birds. The carrier state, in which birds harbor the organism without detectable shedding, complicates surveillance and control.

Vaccination Strategies

Vaccination aims to reduce intestinal colonization, prevent systemic spread, and minimize egg contamination. Two main vaccine types are used in poultry: live attenuated vaccines and inactivated (killed) vaccines. Each type elicits distinct immune responses and has specific advantages and limitations.

Live Attenuated Vaccines

Live vaccines are derived from mutant strains of Salmonella enteritidis with deletions in metabolic or regulatory genes. Common mutations include deletions in the aroA, cya, crp, or htrA genes, which attenuate virulence while preserving immunogenicity. These vaccines are administered orally via drinking water or by spray, mimicking natural infection. They induce a robust mucosal immune response, including secretory IgA (sIgA) in the intestinal lumen, and a cell-mediated response characterized by Th1-type cytokines such as interferon-gamma (IFN-gamma). The activation of macrophages and cytotoxic T lymphocytes is essential for clearing intracellular bacteria.

Live vaccines confer strong protection against intestinal colonization and reduce fecal shedding. However, they carry a residual risk of reversion to virulence, although modern deletion mutants are considered stable. Interference from maternally derived antibodies can reduce efficacy in young chicks. Additionally, live vaccines may persist in the environment and complicate serological surveillance by inducing antibodies that are indistinguishable from those generated by field infection.

Inactivated Vaccines

Inactivated vaccines consist of whole bacterial cells or subunit antigens (e.g., lipopolysaccharide, flagellin, outer membrane proteins) emulsified in an adjuvant. They are administered parenterally, typically by intramuscular or subcutaneous injection. Inactivated vaccines stimulate a strong humoral immune response, producing IgG antibodies in serum and IgY in egg yolk. These antibodies can neutralize bacteria in the bloodstream and reduce systemic dissemination. However, inactivated vaccines are less effective at inducing mucosal immunity and cell-mediated responses compared to live vaccines.

The primary advantage of inactivated vaccines is their safety profile; they cannot revert to virulence. They are suitable for use in layers and breeders where egg production is a concern. However, they require individual handling for injection, which is labor-intensive and stressful for birds. Booster doses are necessary to maintain protective antibody titers.

Comparative Efficacy

The comparative efficacy of live and inactivated vaccines has been evaluated in numerous experimental and field studies. Live vaccines generally provide superior reduction in cecal colonization and fecal shedding. Inactivated vaccines are more effective at preventing egg contamination by reducing the number of bacteria that reach the reproductive tract. A combined strategy using a live vaccine for priming followed by an inactivated vaccine for boosting has been shown to optimize both mucosal and systemic immunity.

Table 1 summarizes the key differences between live and inactivated Salmonella enteritidis vaccines.

| Feature | Live Attenuated Vaccine | Inactivated Vaccine | |, - |, - |, - | | Route of administration | Oral (drinking water, spray) | Parenteral (injection) | | Immune response | Mucosal sIgA, Th1 cell-mediated | Systemic IgG, humoral | | Reduction in cecal colonization | High | Moderate | | Reduction in fecal shedding | High | Low to moderate | | Reduction in egg contamination | Moderate | High | | Safety risk | Low (reversion possible) | None | | Labor requirement | Low | High | | Interference from maternal antibodies | Yes | Minimal | | Serological differentiation | Difficult | Possible with DIVA |

Impact on Egg Contamination

Egg contamination occurs through two routes: transovarian transmission, where bacteria are deposited in the yolk or albumen before shell formation, and horizontal contamination, where bacteria penetrate the shell after oviposition. Vaccination reduces egg contamination primarily by lowering the bacterial load in the reproductive tract. Inactivated vaccines are particularly effective at inducing high levels of circulating IgY, which can be transferred to the egg and provide passive protection to the developing embryo. Live vaccines reduce the risk of transovarian transmission by limiting systemic spread from the intestine.

Quantitative studies using qPCR and culture methods have demonstrated that vaccinated flocks have significantly lower prevalence of Salmonella enteritidis in eggs compared to unvaccinated flocks. The reduction is dose-dependent, with higher vaccine titers correlating with greater protection. However, vaccination does not completely eliminate the risk of egg contamination, and it must be combined with other control measures such as biosecurity, hygiene, and monitoring.

Fecal Shedding Dynamics

Fecal shedding of Salmonella enteritidis is intermittent and influenced by host factors, environmental conditions, and vaccination status. Unvaccinated birds typically exhibit a peak in shedding within the first two weeks post-infection, followed by a gradual decline. However, a subset of birds becomes persistent shedders, maintaining detectable levels of bacteria in feces for weeks or months. Stressors such as molting, transport, and coinfection with other pathogens can reactivate shedding.

Vaccination alters the shedding dynamics by reducing the peak bacterial load and shortening the duration of shedding. Live vaccines are more effective at reducing the magnitude of shedding, while inactivated vaccines have a lesser impact on fecal excretion. The reduction in shedding is critical for decreasing environmental contamination and transmission to other birds.

Quantitative PCR Monitoring of Shedding

Quantitative PCR (qPCR) has become the standard method for monitoring fecal shedding of Salmonella enteritidis. The assay targets conserved genes such as invA, sdfI, or sefA, which are specific to Salmonella enteritidis. DNA is extracted from fecal samples or cloacal swabs, and the cycle threshold (Ct) value is used to estimate the bacterial load. qPCR offers several advantages over traditional culture methods: it is faster, more sensitive, and can detect viable but non-culturable cells. However, it cannot distinguish between live and dead bacteria, which may lead to overestimation of infectious risk.

The use of qPCR in longitudinal studies has revealed the heterogeneity of shedding patterns within flocks. Some birds shed consistently high numbers of bacteria, while others shed intermittently or at low levels. This information is valuable for identifying super-shedders, which are responsible for a disproportionate amount of environmental contamination. Targeted vaccination or culling of super-shedders can reduce the overall transmission rate.

A typical workflow for qPCR monitoring of Salmonella enteritidis in poultry flocks is illustrated in the Mermaid diagram below.

flowchart TD
    A[Fecal sample collection], > B[DNA extraction]
    B, > C[Quantitative PCR targeting invA gene]
    C, > D{Ct value analysis}
    D, >|Ct < 30| E[High shedding]
    D, >|30 <= Ct < 35| F[Moderate shedding]
    D, >|Ct >= 35| G[Low or no shedding]
    E, > H[Intervention: vaccination review, biosecurity]
    F, > H
    G, > I[Continue routine monitoring]
    H, > J[Re-sampling after 2 weeks]
    J, > A

Integration with Other Control Measures

Vaccination is most effective when integrated with comprehensive biosecurity and management practices. These include all-in-all-out production, cleaning and disinfection of facilities, control of rodents and insects, and monitoring of feed and water sources. The use of competitive exclusion products, such as probiotics containing Lactobacillus or Bifidobacterium species, can further reduce Salmonella colonization by occupying ecological niches in the gut.

Surveillance programs that combine qPCR with serological testing (e.g., ELISA for anti-LPS antibodies) provide a complete picture of flock infection status. Serology can detect past exposure, while qPCR identifies active shedding. This dual approach is essential for verifying the effectiveness of vaccination programs and for early detection of breakthrough infections.

Challenges and Future Directions

Despite the success of vaccination, several challenges remain. The emergence of vaccine-resistant strains, although rare, is a theoretical concern. The diversity of Salmonella enteritidis phage types may require multivalent vaccines for broad protection. Additionally, the cost of vaccination, particularly for inactivated vaccines requiring individual injection, can be prohibitive for small-scale producers.

Future research is focused on developing novel vaccine platforms, including recombinant vector vaccines (e.g., using attenuated fowl poxvirus or Salmonella Typhimurium as a carrier) and DNA vaccines. These platforms can deliver multiple antigens and induce both mucosal and systemic immunity. Advances in bioinformatics and genomics are enabling the identification of conserved protective antigens that could lead to cross-protective vaccines against multiple serovars.

The application of metagenomics and next-generation sequencing to monitor the gut microbiome and its interaction with Salmonella is another promising area. Understanding how the microbiome influences colonization resistance and vaccine efficacy could lead to microbiome-based interventions.

Conclusion

Salmonella enteritidis remains a significant challenge for the poultry industry. Vaccination, using either live or inactivated vaccines, is a cornerstone of control programs. Live vaccines are superior for reducing intestinal colonization and fecal shedding, while inactivated vaccines are more effective at preventing egg contamination. A combined vaccination strategy offers the best overall protection. Quantitative PCR is an indispensable tool for monitoring shedding dynamics and evaluating vaccine efficacy. Continued research into novel vaccines and integrated control strategies is essential for reducing the burden of Salmonella enteritidis in poultry flocks.

References

  1. Barrow PA. Salmonella infections: immune and non-immune protection. Avian Pathol. 1991;20(3):385-396.
  2. Gast RK, Holt PS. Influence of molting on Salmonella enteritidis infection in laying hens. Avian Dis. 1995;39(3):539-544.
  3. Hassan JO, Curtiss R. Development and evaluation of an experimental vaccination program using a live avirulent Salmonella typhimurium strain to protect immunized chickens against challenge with homologous and heterologous Salmonella serotypes. Infect Immun. 1994;62(12):5519-5527.
  4. Methner U, Barrow PA, Berndt A, Steinbach G. Combination of vaccination and competitive exclusion to prevent Salmonella colonization in chickens. Avian Dis. 1999;43(4):679-686.
  5. Timoney JF, Shivaprasad HL, Baker RC, Rowe B. Egg transmission after infection of hens with Salmonella enteritidis phage type 4. Vet Rec. 1989;125(24):600-601.
  6. Cooper GL, Venables LM, Woodward MJ, Hormaeche CE. Vaccination of chickens with strain CVL30, a genetically defined Salmonella enteritidis aroA live oral vaccine candidate. Infect Immun. 1994;62(11):4747-4754.
  7. Nakamura M, Nagamine N, Takahashi T, Suzuki S, Sato S. Evaluation of the efficacy of a bacteria against Salmonella enteritidis infection in laying hens. Avian Dis. 1994;38(3):521-526.
  8. Van Immerseel F, Methner U, Rychlik I, et al. Vaccination and early protection against Salmonella infection in poultry. Avian Pathol. 2005;34(3):177-186.
  9. Desmidt M, Ducatelle R, Mast J, et al. Role of the humoral immune response in the protection of chickens against Salmonella enteritidis infection. Vet Immunol Immunopathol. 1998;63(4):323-334.
  10. Beal RK, Wigley P, Powers C, Hulme SD, Barrow PA, Smith AL. Age at primary infection with Salmonella enterica serovar Typhimurium in the chicken influences persistence of infection and subsequent immunity. Infect Immun. 2004;72(12):7132-7138.
  11. Berndt A, Methner U. Gamma/delta T cell response of chickens after oral administration of attenuated and non-attenuated Salmonella typhimurium strains. Vet Immunol Immunopathol. 2001;78(2):143-153.
  12. Withanage GS, Wigley P, Kaiser P, et al. Cytokine and chemokine responses associated with clearance of a primary Salmonella enterica serovar Typhimurium infection in the chicken. Infect Immun. 2005;73(8):5173-5182.
  13. Babu U, Scott M, Myers MJ, et al. Effects of live attenuated and killed Salmonella vaccines on T-lymphocyte mediated immunity in laying hens. Vet Immunol Immunopathol. 2003;91(1):39-44.
  14. Holt PS, Gast RK, Porter RE, Anderson KE. Use of a live oral Salmonella enteritidis vaccine to reduce egg contamination in experimentally infected laying hens. Avian Dis. 2003;47(3):585-590.
  15. Woodward MJ, Gettinby G, Breslin MF, Corkish JD, Houghton S. The efficacy of Salenvac, a Salmonella enterica subsp. enterica serotype Enteritidis iron-regulated protein vaccine, in laying chickens. Avian Pathol. 2002;31(4):383-392.
  16. Gantois I, Ducatelle R, Pasmans F, et al. Mechanisms of egg contamination by Salmonella enteritidis. FEMS Microbiol Rev. 2009;33(4):718-738.
  17. De Buck J, Van Immerseel F, Haesebrouck F, Ducatelle R. Colonization of the chicken reproductive tract and egg contamination by Salmonella. J Appl Microbiol. 2004;97(2):233-245.
  18. Keller LH, Benson CE, Krotec K, Eckroade RJ. Salmonella enteritidis colonization of the reproductive tract and forming and freshly laid eggs of chickens. Infect Immun. 1995;63(7):2443-2449.
  19. Gast RK, Holt PS. Persistence of Salmonella enteritidis in experimentally infected laying hens. Avian Dis. 1998;42(1):155-160.
  20. Van Immerseel F, De Buck J, Boyen F, et al. Dynamics of immune response and colonization in chickens after infection with Salmonella enteritidis. Avian Pathol. 2004;33(4):405-412.
  21. Rychlik I, Barrow PA. Salmonella stress management and its relevance to behaviour during intestinal colonisation and infection. FEMS Microbiol Rev. 2005;29(5):1021-1040.
  22. Malorny B, Hoorfar J, Bunge C, Helmuth R. Multicenter validation of the analytical accuracy of Salmonella PCR: towards an international standard. Appl Environ Microbiol. 2003;69(1):290-296.
  23. Hoorfar J, Ahrens P, Rådström P. Automated 5' nuclease PCR assay for identification of Salmonella enterica. J Clin Microbiol. 2000;38(9):3429-3435.
  24. Eyigor A, Carli KT, Unal CB. Implementation of real-time PCR to detect Salmonella in chicken meat and environmental samples. J Food Prot. 2002;65(11):1719-1724.
  25. Singer RS, Cooke CL, Maddox CW, Isaacson RE. Use of pooled samples for the detection of Salmonella in feces by polymerase chain reaction. J Vet Diagn Invest. 2006;18(4):319-325.
  26. Carrique-Mas JJ, Davies RH. Sampling and bacteriological detection of Salmonella in poultry and poultry premises: a review. Rev Sci Tech. 2008;27(3):665-677.
  27. Wales AD, Davies RH. A critical review of Salmonella Typhimurium infection in laying hens. Avian Pathol. 2011;40(5):429-436.
  28. Foley SL, Nayak R, Hanning IB, Johnson TJ, Han J, Ricke SC. Population dynamics of Salmonella enterica serotypes in commercial egg and poultry production. Appl Environ Microbiol. 2011;77(13):4273-4279.
  29. Andino A, Hanning I. Salmonella enterica: survival, colonization, and virulence differences among serovars. ScientificWorldJournal. 2015;2015:520179.
  30. Bearson BL, Bearson SM. The role of the QseC quorum-sensing sensor kinase in colonization and norepinephrine-enhanced motility of Salmonella enterica serovar Typhimurium. Microb Pathog. 2008;44(4):271-278.
  31. Methner U, Barrow PA, Gregorova D, Rychlik I. Intestinal colonisation-inhibition and virulence of Salmonella phoP, rpoS and ompR deletion mutants in chickens. Vet Microbiol. 2004;98(1):37-43.
  32. Bohez L, Ducatelle R, Pasmans F, et al. Salmonella enterica serovar Enteritidis colonization of the chicken caecum requires the HilA regulatory protein. Vet Microbiol. 2006;116(1-3):202-210.
  33. Raspoet R, Appia-Ayme C, Shearer N, et al. The role of the Salmonella enterica serovar Enteritidis O-antigen in intestinal colonization and egg contamination. Vet Res. 2014;45(1):1-11.
  34. Clavijo RI, Loui C, Andersen GL, Riley LW, Lu S. Identification of genes associated with survival of Salmonella enterica serovar Enteritidis in chicken egg albumen. Appl Environ Microbiol. 2006;72(2):1055-1064.
  35. Guard-Petter J. The chicken, the egg and Salmonella enteritidis. Environ Microbiol. 2001;3(7):421-430.
  36. Humphrey TJ. Contamination of eggs and poultry meat with Salmonella enteritidis: a review. World's Poult Sci J. 1994;50(2):139-155.
  37. Henzler DJ, Opitz HM. The role of mice in the epizootiology of Salmonella enteritidis infection on chicken layer farms. Avian Dis. 1992;36(3):625-631.
  38. Davies RH, Wray C. An approach to the identification of risk factors for Salmonella enteritidis infection of laying hens. Vet Rec. 1996;138(16):385-388.
  39. Van Hoorebeke S, Van Immerseel F, Haesebrouck F, Ducatelle R. The influence of the housing system on Salmonella infections in laying hens: a review. Avian Pathol. 2011;40(3):225-233.
  40. De Vylder J, Dewulf J, Van Hoorebeke S, et al. Horizontal transmission of Salmonella enteritidis in groups of experimentally infected laying hens housed in different housing systems. Poult Sci. 2011;90(7):1391-1396.
  41. Holt PS, Davies RH, Dewulf J, et al. The impact of different housing systems on egg safety and quality. Poult Sci. 2011;90(2):251-262.
  42. Ricke SC. Perspectives on the use of organic acids and short chain fatty acids as antimicrobials. Poult Sci. 2003;82(4):632-639.
  43. Nisbet DJ. Defined competitive exclusion cultures in the prevention of enteropathogen colonisation in poultry and swine. Antonie Van Leeuwenhoek. 2002;81(1-4):481-486.
  44. Patterson JA, Burkholder KM. Application of prebiotics and probiotics in poultry production. Poult Sci. 2003;82(4):627-631.
  45. Revolledo L, Ferreira AJ, Mead GC. Prospects in Salmonella control: competitive exclusion, probiotics, and other alternatives. J Appl Poult Res. 2006;15(2):341-351.
  46. Barrow PA, Lovell MA, Berchieri A. Immunisation of laying hens against Salmonella enteritidis with live attenuated vaccines. Vet Rec. 1990;126(10):241-242.
  47. Timms LM, Marshall RN, Breslin MF. Laboratory assessment of protection given by an experimental Salmonella enteritidis inactivated vaccine in laying hens. Vet Rec. 1994;134(20):506-509.
  48. Gast RK, Stone HD, Holt PS, Beard CW. Evaluation of the efficacy of an oil-emulsion bacteria for protecting chickens against Salmonella enteritidis. Avian Dis. 1992;36(4):992-999.
  49. Nakamura M, Nagamine N, Takahashi T, Suzuki S, Sato S. Evaluation of the efficacy of a bacteria against Salmonella enteritidis infection in laying hens. Avian Dis. 1994;38(3):521-526.
  50. Liu F, Kariyawasam S, Jayarao BM, et al. Subtyping of Salmonella enterica serovar Enteritidis isolates from poultry and human sources using pulsed-field gel electrophoresis and antimicrobial susceptibility testing. Foodborne Pathog Dis. 2011;8(4):527-533.